Blood storage duration and biochemical recurrence of cancer after radical prostatectomy

Mayo Clinic Proceedings

Volumn 86, Issue 2, 2011, Pages 120-127

  Cata, Juan P ^a   Klein, Eric A ^a   Hoeltge, Gerald A ^a   Dalton, Jarrod E ^a   Mascha, Edward ^a   O'Hara, Jerome ^a   Russell, Amanda ^a   Kurz, Andrea ^a   Ben Elihayhu, Shamgar ^b   Sessler, Daniel I ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOTRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; SURVIVAL RATE;

EID: 79551678745     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0313     Document Type: Article

References (45)

1. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am. 2001;28(3):555-565. (Pubitemid 32916759)
2. Zincke H, Bergstralh EJ, Blute ML, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol. 1994;12(11):2254-2263. (Pubitemid 24346692)
3. Acharya SS, Zorn KC, Shikanov S, et al. Evolution of open radical retropubic prostatectomy: how have open surgeons responded to the challenge of minimally invasive surgery? J Endourol. 2009;23(11):1893-1897.
4. Gonzalgo ML, Pavlovich CP, Trock BJ, Link RE, Sullivan W, Su LM. Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol. 2005;174(1):135-139.
5. Touijer K, Eastham JA, Secin FP, et al. Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. J Urol. 2008;179(5):1811-1817.
6. Ou YC, Yang CR, Wang J, Cheng CL, Patel VR. Comparison of robotic-assisted versus retropubic radical prostatectomy performed by a single surgeon. Anticancer Res. 2009;29(5):1637-1642.
7. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology. 1999;91(3):861-865.
8. Vamvakas EC. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results? Vox Sang. 2007;93(3):196-207.
9. van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. Pretransplantation blood transfusion revisited. N Engl J Med. 1991;325(17):1210-1213.
10. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992;79(6):513-516.
11. Francis DM. Relationship between blood transfusion and tumour behaviour. Br J Surg. 1991;78(12):1420-1428.
12. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg. 1993;80(4):427-432.
13. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97(5):1180-1195.
14. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994;344(8922):573-578.
15. van de Watering LM, Brand A, Houbiers JG, Klein Kranenbarg WM, Hermans J, van de Velde C. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg. 2001;88(2):267-272. (Pubitemid 32142717)
16. Eickhoff JH, Gote H, Baeck J. Peri-operative blood transfusion in relation to tumour recurrence and death after surgery for prostatic cancer. Br J Urol. 1991;68(6):608-611.
17. Atzil S, Arad M, Glasner A, et al. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology. 2008;109(6):989-997.
18. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229-1239.
19. Stephenson AJ, Kattan MW, Eastham JA, et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol. 2006;24(24):3973-3978.
20. Chin-Yee I, Arya N, d'Almeida MS. The red cell storage lesion and its implication for transfusion. Transfus Sci. 1997;18(3):447-458.
21. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev. 2001;15(2):91-107. (Pubitemid 32303574)
22. Sparrow RL, Veale MF, Healey G, Payne KA. Red blood cell (RBC) age at collection and storage influences RBC membrane-associated carbohydrates and lectin binding. Transfusion. 2007;47(6):966-968.
23. Berezina TL, Zaets SB, Morgan C, et al; Danish RANX05 Colorectal Cancer Study Group. Influence of storage on red blood cell rheological properties. J Surg Res. 2002;102(1):6-12.
24. Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Scand J Gastroenterol. 2000;35(2):212-217.
25. Weinberg JA, McGwin G Jr, Griffin RL, et al. Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma. 2008;65(2):279-282.
26. Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion: is blood storage time important? Dis Colon Rectum. 1990;33(2):127-130. (Pubitemid 20063592)
27. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995;35(9):760-768.
28. Dionigi G, Rovera F, Boni L, et al. The impact of perioperative blood transfusion on clinical outcomes in colorectal surgery. Surg Oncol. 2007;16(suppl 1):S177-S182.
29. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce longterm survival following surgery for colorectal cancer. Dis Colon Rectum. 1998;41(4):451-459. (Pubitemid 28169670)
30. Mynster T, Nielsen HJ. Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum. 2001;44(7):955-964.
31. Gao CL, Rawal SK, Sun L, et al. Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients. Clin Cancer Res. 2003;9(7):2545-2550.
32. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion- associated postoperative infection. Transfus Med Rev. 2002;16(2):144-160.
33. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21(6):327-348.
34. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193(11):1303-1310. (Pubitemid 32524780)
35. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol. 2008;9(3):239-244.
36. Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg. 2009;208(1):110-119.
37. Berardi R, Brunelli A, Tamburrano T, et al. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer. 2005;49(3):371-376.
38. Sadallah S, Eken C, Schifferli JA. Erythrocyte-derived ectosomes have immunosuppressive properties. J Leukoc Biol. 2008;84(5):1316-1325.
39. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood. 1993;81(7):1880-1882. (Pubitemid 23101603)
40. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood. 1994;84(1):344-348.
41. Clark DA, Gorczynski RM, Blajchman MA. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Transfusion. 2008;48(5):814-821.
42. Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28(6):576-579.
43. Amato AC, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum. 1998;41(5):570-585.
44. Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology. 2006;67(1):137-141.
45. Nuttall GA, Cragun MD, Hill DL, et al. Radical retropubic prostatectomy and blood transfusion. Mayo Clin Proc. 2002;77(12):1301-1305.